Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2019, Article ID 4608315, 8 pages
https://doi.org/10.1155/2019/4608315
Research Article

Are Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjects

1Department of Research, Innlandet Hospital Trust, PB 104, N-2381 Brumunddal, Norway
2Unit for Applied Clinical Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Box 8905, N-7491 Trondheim, Norway
3Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Box 8905, N-7491 Trondheim, Norway
4Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, N-0440 Oslo, Norway

Correspondence should be addressed to Per G. Farup; on.untn@puraf.rep

Received 10 March 2019; Revised 28 May 2019; Accepted 31 August 2019; Published 1 October 2019

Academic Editor: Aron Weller

Copyright © 2019 Per G. Farup et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Fact Sheet N 311, Obesity and Overweight, WHO, Geneva, Switzerland, 2019, http://www.who.int/mediacentre/factsheets/fs311/en/.
  2. M. Abdelaal, C. W. le Roux, and N. G. Docherty, “Morbidity and mortality associated with obesity,” Annals of Translational Medicine, vol. 5, no. 7, p. 161, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. D. P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis, “The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis,” BMC Public Health, vol. 9, no. 1, p. 88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. WHO, Controlling the Global Obesity Epidemic, WHO, Geneva, Switzerland, 2019, http://www.who.int/nutrition/topics/obesity/en/.
  5. L. A. David, C. F. Maurice, R. N. Carmody et al., “Diet rapidly and reproducibly alters the human gut microbiome,” Nature, vol. 505, no. 7484, pp. 559–563, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Bouter, D. H. van Raalte, A. K. Groen, and M. Nieuwdorp, “Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction,” Gastroenterology, vol. 152, no. 7, pp. 1671–1678, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Del Chierico, F. Abbatini, A. Russo et al., “Gut microbiota markers in obese adolescent and adult patients: age-dependent differential patterns,” Frontiers in Microbiology, vol. 9, p. 1210, 2018. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Castaner, A. Goday, Y.-M. Park et al., “The gut microbiome profile in obesity: a systematic review,” International Journal of Endocrinology, vol. 2018, Article ID 4095789, 9 pages, 2018. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Gao, C. Zhu, H. Li et al., “Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity,” Obesity, vol. 26, no. 2, pp. 351–361, 2018. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Arora, R. Sharma, and G. Frost, “Propionate. Anti-obesity and satiety enhancing factor?” Appetite, vol. 56, no. 2, pp. 511–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. K. Chakraborti, “New-found link between microbiota and obesity,” World Journal of Gastrointestinal Pathophysiology, vol. 6, no. 4, pp. 110–119, 2015. View at Publisher · View at Google Scholar
  12. Z. Li, C.-X. Yi, S. Katiraei et al., “Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit,” Gut, vol. 67, no. 7, pp. 1269–1279, 2018. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. H. Al-Lahham, M. P. Peppelenbosch, H. Roelofsen, R. J. Vonk, and K. Venema, “Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, vol. 1801, no. 11, pp. 1175–1183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Andoh, A. Nishida, K. Takahashi et al., “Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population,” Journal of Clinical Biochemistry and Nutrition, vol. 59, no. 1, pp. 65–70, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Koliada, G. Syzenko, V. Moseiko et al., “Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population,” BMC Microbiology, vol. 17, no. 1, p. 120, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Rajilic-Stojanovic and W. M. de Vos, “The first 1000 cultured species of the human gastrointestinal microbiota,” FEMS Microbiology Reviews, vol. 38, pp. 996–1047, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. H. Bell, “Changes seen in gut bacteria content and distribution with obesity: causation or association?” Postgraduate Medicine, vol. 127, no. 8, pp. 863–868, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. G. D. Wu, J. Chen, C. Hoffmann et al., “Linking long-term dietary patterns with gut microbial enterotypes,” Science, vol. 334, no. 6052, pp. 105–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. P. Scott, S. H. Duncan, and H. J. Flint, “Dietary fibre and the gut microbiota,” Nutrition Bulletin, vol. 33, no. 3, pp. 201–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Montandon and F. R. Jornayvaz, “Effects of antidiabetic drugs on gut microbiota composition,” Genes, vol. 8, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Wu, E. Esteve, V. Tremaroli et al., “Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug,” Nature Medicine, vol. 23, no. 7, pp. 850–858, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Suez, T. Korem, D. Zeevi et al., “Artificial sweeteners induce glucose intolerance by altering the gut microbiota,” Nature, vol. 514, no. 7521, pp. 181–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Suez, T. Korem, G. Zilberman-Schapira, E. Segal, and E. Elinav, “Non-caloric artificial sweeteners and the microbiome: findings and challenges,” Gut Microbes, vol. 6, no. 2, pp. 149–155, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Feehley and C. R. Nagler, “The weighty costs of non-caloric sweeteners,” Nature, vol. 514, no. 7521, pp. 176-177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. G. Farup, M. Aasbrenn, and J. Valeur, “Separating “good” from “bad” faecal dysbiosis—evidence from two cross-sectional studies,” BMC Obesity, vol. 5, no. 1, p. 30, 2018. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Shanahan, D. van Sinderen, P. W. O’Toole, and C. Stanton, “Feeding the microbiota: transducer of nutrient signals for the host,” Gut, vol. 66, no. 9, pp. 1709–1717, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Winther, M. Aasbrenn, and P. G. Farup, “Intake of non-nutritive sweeteners is associated with an unhealthy lifestyle: a cross-sectional study in subjects with morbid obesity,” BMC Obesity, vol. 4, no. 1, p. 41, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Farup and J. Valeur, “Faecal microbial markers and psychobiological disorders in subjects with morbid obesity. A cross-sectional study,” Behavioral Sciences, vol. 8, no. 10, p. 89, 2018. View at Publisher · View at Google Scholar · View at Scopus
  29. The Norwegian food composition table, 2019, http://www.matvaretabellen.no/?language=en.
  30. C. Casén, H. C. Vebø, M. Sekelja et al., “Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD,” Alimentary Pharmacology & Therapeutics, vol. 42, no. 1, pp. 71–83, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. Genetic Analysis AS, “GAMap TM dysbiosis test,” 2019, http://www.genetic-analysis.com/patent. View at Google Scholar
  32. J. B. Zijlstra, J. Beukema, B. G. Wolthers, B. M. Byrne, A. Groen, and J. D. Ankert, “Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samples,” Clinica Chimica Acta, vol. 78, no. 2, pp. 243–250, 1977. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Høverstad, A. Bjørneklett, T. Midtvedt, O. Fausa, and T. Bøhmer, “Short-chain fatty acids in the proximal gastrointestinal tract of healthy subjects,” Scandinavian Journal of Gastroenterology, vol. 19, pp. 1053–1058, 1984. View at Google Scholar
  34. B. Tjellström, L. Högberg, L. Stenhammar et al., “Effect of exclusive enteral nutrition on gut microflora function in children with Crohn’s disease,” Scandinavian Journal of Gastroenterology, vol. 47, no. 12, pp. 1454–1459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. F. Hayes and N. J. Rockwood, “Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation,” Behaviour Research and Therapy, vol. 98, pp. 39–57, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. A. F. Hayes, Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach, Guilford Press, New York, NY, USA, Second edition, 2018.
  37. T. Uebanso, A. Ohnishi, R. Kitayama et al., “Effects of low-dose non-caloric sweetener consumption on gut microbiota in mice,” Nutrients, vol. 9, no. 6, p. 560, 2017. View at Publisher · View at Google Scholar
  38. R. B. Canani, M. D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano, “Potential beneficial effects of butyrate in intestinal and extraintestinal diseases,” World Journal of Gastroenterology, vol. 17, no. 12, pp. 1519–1528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Whitt, V. Woo, P. Lee et al., “Disruption of epithelial HDAC3 in intestine prevents diet-induced obesity in mice,” Gastroenterology, vol. 155, no. 2, pp. 501–513, 2018. View at Publisher · View at Google Scholar · View at Scopus
  40. K. S. Fluitman, M. Wijdeveld, M. Nieuwdorp, and R. G. Ijzerman, “Potential of butyrate to influence food intake in mice and men,” Gut, vol. 67, no. 7, pp. 1203-1204, 2018. View at Publisher · View at Google Scholar · View at Scopus
  41. F. De Vadder, P. Kovatcheva-Datchary, D. Goncalves et al., “Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits,” Cell, vol. 156, pp. 84–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Crézé, L. Candal, J. Cros et al., “The impact of caloric and non-caloric sweeteners on food intake and brain responses to food: a randomized crossover controlled trial in healthy humans,” Nutrients, vol. 10, no. 5, p. 615, 2018. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Toews, S. Lohner, D. Küllenberg de Gaudry, H. Sommer, and J. J. Meerpohl, “Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies,” BMJ, vol. 364, p. k4718, 2019. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Feng, H. Tang, M. Li et al., “The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults,” Archives of Microbiology, vol. 196, no. 1, pp. 73–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. C. V. Ferreira-Halder, A. V. d. S. Faria, and S. S. Andrade, “Action and function of Faecalibacterium prausnitzii in health and disease,” Best Practice & Research Clinical Gastroenterology, vol. 31, no. 6, pp. 643–648, 2017. View at Publisher · View at Google Scholar · View at Scopus
  46. H. J. Flint, K. P. Scott, S. H. Duncan, P. Louis, and E. Forano, “Microbial degradation of complex carbohydrates in the gut,” Gut Microbes, vol. 3, no. 4, pp. 289–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Louis and H. J. Flint, “Formation of propionate and butyrate by the human colonic microbiota,” Environmental Microbiology, vol. 19, no. 1, pp. 29–41, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Luo, X. Wang, and G. Zhang, “The anti-obesity effect of starch in a whole grain-like structural form,” Food & Function, vol. 9, no. 7, pp. 3755–3763, 2018. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Forslund, F. Hildebrand, T. Nielsen et al., “Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota,” Nature, vol. 528, no. 7581, pp. 262–266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. K. J. Rothman, “Six persistent research misconceptions,” Journal of General Internal Medicine, vol. 29, no. 7, pp. 1060–1064, 2014. View at Publisher · View at Google Scholar · View at Scopus